You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ductal

Showing 1 - 25 of 1,864
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atypical Ductal Hyperplasia, Ductal Carcinoma in Situ Trial in Milan (Vacuum-assisted excisional biopsy)

Recruiting
  • Atypical Ductal Hyperplasia
  • Ductal Carcinoma in Situ
  • Vacuum-assisted excisional biopsy
  • Milan, Italy
    Breast Imaging Division, Radiology Department, IEO European Inst
Jun 27, 2023

Ductal Carcinoma in Situ Trial (Tamoxifen, Exemestane, Letrozole)

Not yet recruiting
  • Ductal Carcinoma in Situ
  • (no location specified)
Oct 13, 2023

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Boston (other, diagnostic test, combination product)

Not yet recruiting
  • Pancreatic Cancer
  • +4 more
  • Screening Blood Tests
  • +3 more
  • Boston, Massachusetts
  • +1 more
Nov 3, 2023

Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy

Completed
  • Ductal Carcinoma in Situ
  • Mastectomy with sentinel lymph node biopsy
  • (no location specified)
Jul 17, 2023

Pancreatic Ductal Adenocarcinoma, Pain, Acute Trial in San Francisco (Ketamine, Meaning and Purpose therapy)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Pain, Acute
  • San Francisco, California
    University of California, San Francisco
Oct 12, 2023

Pancreatic Ductal Adenocarcinoma, Oligometastatic Disease Trial in Baltimore (FOLFIRINOX chemo)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Oligometastatic Disease
  • FOLFIRINOX chemotherapy
  • Baltimore, Maryland
    Johns Hopkins Hospital
Nov 2, 2023

Most Total Pancreatectomies for Ductal Adenocarcinoma Can Be

Recruiting
  • Ductal Adenocarcinoma of the Pancreas
  • Whipple over the splenic artery
  • Total pancreatectomy
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 1, 2023

Minimal Residual Disease Using Multi-omics Approach

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test
  • Shanghai, China
    Department of Pancreatic and Hepatobiliary Surgery, Fudan Univer
Nov 29, 2023

Carcinoma, Pancreatic Ductal Trial in Trondheim (SonoVue, Chemotherapy)

Completed
  • Carcinoma, Pancreatic Ductal
  • Trondheim, Norway
    Department of Radiology, St Olavs Hospital
Jan 17, 2023

Nipple Discharge Trial in Wuhan (contrast-enhanced spectral mammography)

Recruiting
  • Nipple Discharge
  • contrast-enhanced spectral mammography
  • Wuhan, Hubei, China
    Union Hospital of Tongji Medical College of Huazhong University
Sep 11, 2023

Adenocarcinoma, Pancreatic Ductal Trial in New York (Autogene cevumeran, Atezolizumab, mFOLFIRINOX)

Recruiting
  • Adenocarcinoma, Pancreatic Ductal
  • Autogene cevumeran
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 21, 2023

Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Stereotactic body radiotherapy (SBRT)
  • +4 more
  • New York, New York
    Columbia University Irving Medical Center
Sep 15, 2023

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (BXCL701, Pembrolizumab)

Not yet recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Jan 23, 2023

Ductal Carcinoma in Situ Trial in Durham (Decision Support Tool with Active Monitoring, Decision Support Tool without Active

Completed
Has Results
  • Ductal Carcinoma in Situ
  • Decision Support Tool with Active Monitoring
  • Decision Support Tool without Active Monitoring
  • Durham, North Carolina
    Duke Mammography Clinic
Jan 4, 2023

Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor Trial in Petaling Jaya (Dendritic cell + Cytokine-induced killer cell

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Advanced Solid Tumor
  • Dendritic cell + Cytokine-induced killer cell (DC+CIK) immunotherapy
  • Tegafur Only Product
  • Petaling Jaya, Kuala Lumpur, Malaysia
    Clinical Oncology Department, Ummc
Jul 12, 2023

Predict Lymphovascular Invasion in Pancreatic Ductal

Recruiting
  • Predictive Cancer Model
  • Pancreas Cancer
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Aug 10, 2023

    PDAC - Pancreatic Ductal Adenocarcinoma Trial in Nijmegen (CT Perfusion)

    Recruiting
    • PDAC - Pancreatic Ductal Adenocarcinoma
    • CT Perfusion
    • Nijmegen, Gelderland, Netherlands
      Radboud University Medical Hospital
    Dec 20, 2022

    Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Rochester (Bio-specimen Collection: Blood, Bio-specimen

    Recruiting
    • Pancreatic Cancer
    • +3 more
    • Bio-specimen Collection: Blood
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Nov 21, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • +12 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 30, 2022

    Pancreatic Ductal Adenocarcinoma, Refractory NSCLC Trial in Washington (Daratumumab, KRAS vaccine, Nivolumab)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Refractory Non-Small Cell Lung Cancer
    • Washington, District of Columbia
      Georgetown Lombardi Comprehensive Cancer Center
    Sep 1, 2023

    Pancreatic Ductal Adenocarcinoma Trial (NP137, Oxaliplatin, Irinotecan)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • (no location specified)
    Sep 23, 2022

    3D Bioprinting for Personalized Treatment in Pancreatic Ductal

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
      • Beijing, Beijing, China
      • +1 more
      Jul 12, 2023

      Myosteatosis and Creatinine-to-cystatin C Ratio in Pancreatic

      Recruiting
      • Skeletal Muscle Radiodensity
      • +3 more
        • Qingdao, Shandong, China
          the Affiliated Hospital of Qingdao University
        Nov 6, 2022

        Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (Eryaspase,

        Active, not recruiting
        • Locally Advanced Pancreatic Ductal Adenocarcinoma
        • Metastatic Pancreatic Ductal Adenocarcinoma
        • Washington, District of Columbia
          Georgetown Lombardi Comprehensive Cancer Center
        Aug 3, 2022

        Predictive Factors for Resection and Survival in Type A

        Not yet recruiting
        • Carcinoma, Pancreatic Ductal
        • Resection
        • No Resection
        • (no location specified)
        Aug 3, 2022